| LINE ITEM (USD / %) | FY 2025
FILED 2025-11-30 | FY 2024
FILED 2024-11-30 | FY 2023
FILED 2023-11-30 |
|---|---|---|---|
| Revenue (Total Sales) | $9.83B | $9.62B | $7.11B |
| YoY Revenue Growth % | +2.2% | +35.2% | — |
| Gross Profit | $3.44B | $3.45B | — |
| Gross Margin % | 35.0% | 35.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$918.2M | $596.4M | $661.3M |
| Operating Margin % | -9.3% | 6.2% | 9.3% |
| Net Income (GAAP) | -$1.28B | $251.2M | $313.8M |
| EBITDA (Normalized) | -$730.6M | $787.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $807.0M | $667.5M | $678.0M |
| Capital Expenditures (CapEx) | $234.5M | $238.8M | — |
| Free Cash Flow (FCF) | $572.5M | $428.7M | $678.0M |
| FCF Margin % | 5.8% | 4.5% | 9.5% |
| Return on Invested Capital (ROIC %) | -10.4% | 5.5% | — |
| Cash & Short-Term Equivalents | $327.3M | $240.6M | — |
| Total Debt (Short + Long Term) | $4.57B | $4.73B | — |
| Total Stockholders' Equity | $2.74B | $4.04B | — |